Te Poele, R.
94  results:
Search for persons X
?
 
?
3

379 Characterisation of a novel class I isoform selective p..:

Guillard, S. ; Clarke, P.A. ; te Poele, R....
European Journal of Cancer Supplements.  2 (2004)  8 - p. 114 , 2004
 
?
4

414A Pharmacological properties and in vitro and in vivo an..:

Workman, P. ; Raynaud, F. ; Clarke, P....
European Journal of Cancer Supplements.  2 (2004)  8 - p. 124 , 2004
 
?
5

HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800..:

Pasqua, AE ; Sharp, SY ; Chessum, NEA...
Journal of Medicinal Chemistry, 2023, 66 (8), pp. 5907 - 5936.  , 2023
 
?
6

HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800..:

Pasqua, AE ; Sharp, SY ; Chessum, NEA...
https://discovery.ucl.ac.uk/id/eprint/10184910/1/HSF1%20Pathway%20Inhibitor%20Clinical%20Candidate%20%28CCT361814NXP800%29%20Developed%20from%20a%20Phenotypic%20Screen%20as%20a%20Potential%20Treatment%20for%20.pdf.  , 2023
 
?
7

Modulation of Biliary Cancer Chemo-Resistance Through Micro..:

Carotenuto, P ; Hedayat, S ; Fassan, M...
Hepatology (Baltimore, Md.), 2020, 72 (3), pp. 982 - 996.  , 2020
 
?
 
?
10

Discovery of a Chemical Probe Bisamide (CCT251236): An Oral..:

Cheeseman, MD ; Chessum, NEA ; Rye, CS...
Journal of medicinal chemistry, 2017, 60 (1), pp. 180 - 201.  , 2016
 
?
 
?
15

Development of Slowly Digestible Starch Derived α-Glucans w..:

te Poele, E. M. ; Corwin, S. G. ; Hamaker, B. R....
Journal of Agricultural and Food Chemistry.  68 (2020)  24 - p. 6664-6671 , 2020
 
1-15